Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.

A recent lightning rod for abortion opponents, the drug mifepristone—the first of two in the standard medication abortion regimen—surfaced several times during Robert F. Kennedy, Jr.’s first Senate confirmation hearing as President Trump’s pick for Health and Human Services secretary.

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

Mifepristone is under attack by abortion opponents, with several states seeking in federal court to restrict its use.

The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.

Robert F. Kennedy Jr. attempted to walk back his past anti-vaccine and pro-abortion rights stances in his Senate confirmation hearing Wednesday as he fielded questions from both sides of the aisle. The big picture: In his hearing,

Khaya Himmelman spoke to one of the 60,000 voters in North Carolina whose ballots Republican state Supreme Court candidate Jefferson Griffin is trying to get tossed out in order to steal the election from incumbent Democratic Justice Allison Riggs, who won the race by just over 700 votes.

Idaho, Kansas and Missouri took up that banner ... state law enforcement.” Mifepristone was first approved in 2000, though the regulator changed the drug’s approved conditions and lowered ...

Robert F. Kennedy Jr. is back on Capitol Hill for a hearing before the Senate Health, Education, Labor and Pensions committee.

Missouri and Idaho officials say they have a separate ... the FDA to reinstate its restrictions on the medication, requiring mifepristone to be dispensed only in person and be used within the ...

The DOJ and a manufacturer of mifepristone are trying to end the ... the three Intervenor States of Missouri, Idaho, and Kansas (“the States”) wish to continue pressing their claims ...

Robert F. Kennedy Jr., the candidate of the US President Trump, who is a secretary for health and human services, attested on January 29, 2025 to confirm the Senate Financing Committee on Capitol Hill in Washington, USA. In his opening speeches in front of the panel, Kennedy pushed back the claims that he is anti-vaccine or anti-industry.